Here's where the company's been this year, and where it could be going.

1. 3 Things You Need to Know

3. Improved Mobility
 The robot’s arms can be
moved to work on different
areas of the body, without
moving the patient.
 This could open the
machine up to performing
more operations outside of
its core of hysterectomies
and prostatectomies.
 The endoscope is what
allows the surgeon
operating the Xi to see
what is going on.
 Improved imaging is
always a positive for a
medical device company.
While not being a game
changer, this helps cut
down on surgical errors.
New Endoscope

5.  From 2010 to 2013, the company had grown sales
daVinci robots by roughly 35% per year during the first
quarter.
 This year, due to a combination of questions in the
medical community regarding the efficacy of the
daVinci, and tighter budgets due to the onset of the
Affordable Care Act, sales of new daVinci systems
actually fell by an alarming 47%.

7. Xi Adoption
 Don’t expect hospitals to
all of a sudden loosen
the purse strings to buy
the Xi.
 Any type of stabilization
in system sales by the
end of the year would be
a positive sign.
 The Xi model should
allow the daVinci to be
used outside of its
bread-and-butter
hysterectomy and
prostatectomy
procedures.
 Pay attention to any
growth in operations
outside of these two.
General Surgery

8. Investors in Intuitive Surgical got a stark reminder last
year about why it’s important to diversify one’s holdings.
To find out about another ground-breaking healthcare
company, check out our special free report:
Leaked: This Coming Blockbuster Will Make
Every Biotech Jealous